Prevent Blindness partners with Lumata Health to provide more resources
The partnership addresses a major gap in delivering resources for patients with vision impairment or blindness, including a new focus on mental health care delivery.
Q&A: How is the landscape of geographic atrophy changing?
Pegcetacoplan’s recent FDA approval creates an option for patients with dry AMD.
Myopia progression can be decreased by low-dose atropine drops
Atropine 0.01% eye drops decreased myopia progression in children over the study course of 1 year.
A pregnancy sleep-OSA-dry eye triad
Recommending a nighttime eye mask and ear plugs may protect the ocular surface.
This week in optometry: April 3-April 7
A look back on what happened in optometry during the week of April 3-April 7.
AI to predict Graves’ orbitopathy severity
Based on the initial ophthalmic findings, it is difficult but important to predict the patients’ progression to a specific level of disease severity.
Black EyeCare Perspective announces third annual signing day event
The annual signing day is part of BEP's mission and pipeline efforts for Black students in optometry.
Acute- and delayed-onset endophthalmitis: Visual acuity and clinical features after open globe injuries
The researchers undertook a retrospective, comparative, consecutive case series of patients with endophthalmitis after open globe injury.
Controversies in Modern Eye Care symposium celebrates its 17th year
Cochairs stage a triumphant return to in-person meeting.
Identifying domestic violence through ocular injuries
The investigators conducted a retrospective cross-sectional analysis to determine the epidemiologic pattern of IPV–related ocular injuries in US adults
Inaugural IKA symposium shines a light on diagnosing and managing keratoconus
Cochair Elizabeth Yeu, MD, highlights what this program will mean for ophthalmologists, optometrists, and their patients.
Study: Alcohol misuse may negatively affect corneal endothelial cells
The primary outcome was an association between alcohol misuse and corneal endothelial metrics.
Dozens of contamination violations found at recalled eye drop manufacturer's facility
Dirty equipment and sterilization issues are among the many violations found by the FDA.
Going virtual with visual field perimeters
Step up your standard of care, free up office space, and exceed patient expectations by taking advantage of these tools.
New topical therapies for dry eye disease
Nasal spray may fill the gaps left by artificial tears.
Prevent Blindness designates April as Women’s Eye Health and Safety Month
Women are at higher risk of eye disease than men.
This week in optometry: March 27-March 31
A look back on what happened in optometry during the week ofMarch 27-March 31.
FDA approved twice-daily dosing option for Vuity eye drops for presbyopia
Allergan developed VUITY, which it noted is the first and only FDA-approved eye drop to treat presbyopia. The FDA has now approved a two-dose option.
Safety, efficacy of lotilaner ophthalmic solution for Demodex blepharitis treatment
Though there is no current FDA-approved treatment, lotilaner ophthalmic solution, 0.25%, is the first drug designed to treat and target the underlying cause of Demodex blepharitis.
Repeated CXL safe and effective for progressive keratoconus
Because the disease is vision-threatening, the investigators retrospectively reviewed the demographic, clinical, and surgical data from the cases of patients who required additional CXL.
